In the News

Chrysea – delivering precision, healthy lifespa...

Longevity Technology sits down with Chrysea CEO, Pedro de Noronha Pissarra to talk about the company, its raise and its IP.

The Simple Biotech Podcast: ‘Investing in the L...

Dr. Greg Bailey, MD, CEO of Juvenescence discusses innovations in the longevity space in this interview with host James Ruhle of ‘The Simple BioTech Podcast’.

Master Investor 2022: Our CEO, Dr. Greg Bailey,...

Master Investor is one of the leading investor meetings. Our CEO and co-founder gives his views on the future of longevity science, investments that will fund progress, and Juvenescence's role...

Longevity Technology: A new era of healthspan a...

Juvenescence’s new breakthrough C6 Ketone Di-ester product, a GRAS (Generally Recognized as Safe) ingredient, was highlighted in Longevity Technology’s inaugural report, “A new era of healthspan and longevity: Longevity supplements.”...

Buck Institute to study ketone esters and aging

Our partner, the Buck Institute for Research on Aging launched an investigational study on ketones to ascertain how they may support aging. “This is a landmark event at the Buck Institute. It’s...

Juvenescence and Buck Institute Set the (ke)ton...

Dr Brianna Stubbs discusses ketosis research and a new webinar that features leading experts in the ketone metabolism research field.